LICHEN PLANUS, ORAL
Clinical trials for LICHEN PLANUS, ORAL explained in plain language.
Never miss a new study
Get alerted when new LICHEN PLANUS, ORAL trials appear
Sign up with your email to follow new studies for LICHEN PLANUS, ORAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for chronic mouth condition: baricitinib trial launches
Disease control OngoingThis study tests whether baricitinib, a drug used for arthritis, can help people with moderate to severe oral lichen planus—a painful mouth condition. Ten adults who haven't improved with other treatments will take the drug for six months. Researchers will measure changes in mout…
Matched conditions: LICHEN PLANUS, ORAL
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Scientists hunt for clues to why lichen planus treatment fails
Knowledge-focused OngoingThis study follows 110 adults with lichen planus who are using topical steroids, the standard first treatment. Researchers will collect clinical details, saliva, blood, and tissue samples to identify factors linked to poor response. The goal is to understand why some patients don…
Matched conditions: LICHEN PLANUS, ORAL
Sponsor: University of Aberdeen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC